Deinagkistrodon acutus envenomation: a report of three cases

World Health Organization (WHO). Snake antivenoms. Fact sheet N° 337. Reviewed February 2015. Retrieved from http://www.who.int/mediacentre/factsheets/fs337/en/ . Accessed 23 Oct 2016.

Wei CB, Chen J, Li JH. Acutolysin C, a weak hemorrhagic toxin from the venom of Agkistrodon acutus with leucoagglutination activity. J Venom Anim Toxins incl Trop Dis. 2011;17(1):34–41.

Wei CB, Chen J. A novel lipocalin homologue from the venom gland of Deinagkistrodon acutus similar to mammalian lipocalins. J Venom Anim Toxins incl Trop Dis. 2012;18(1):16–23.

Chieh-Fan C, Tzeng-Jih L, Wen-Chi H, Hua-Wei Y. Appropriate antivenom doses for six types of envenomations caused by snakes in Taiwan. J Venom Anim Toxins incl Trop Dis. 2009;15(3):479–90.

Ratanabanangkoon K, Tan KY, Eursakun S, Tan CH, Simsiriwong P, Pamornsakda T, et al. A simple and novel strategy for the production of a pan-specific antiserum against elapid snakes of Asia. PLoS Negl Trop Dis. 2016;10(4):e0004565.

Mao YC, Hung DZ. Epidemiology of snake envenomation in Taiwan. Clinical Toxinology in Asia Pacific and Africa. 2015. p. 3–22. http://link.springer.com/referenceworkentry/10.1007/978-94-007-6386-9_45 . Accessed 21 Feb 2017.

Uetz P, Hošek J. The Reptile Database. Retrieved from http://www.reptile-database.org/ . Accessed 8 Dec 2014.

Mao YC, Hung DZ. Management of snake envenomation in Taiwan. Clinical Toxinology in Asia Pacific and Africa. 2015. p. 23–52. http://link.springer.com/referenceworkentry/10.1007/978-94-007-6386-9_43 . Accessed 21 Feb 2017.

Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G, et al. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2008;133(6_Suppl):160S–98.

Williamson DR, Albert M, Heels-Ansdell D, Arnold DM, Lauzier F, Zarychanski R, et al. Thrombocytopenia in critically ill patients receiving thromboprophylaxis: frequency, risk factors, and outcomes. Chest. 2013;144(4):1207–15.

Shen MC. Afibrinogenemia and thrombocytopenia following crotalid snake bites in Taiwan. J Formos Med Assoc. 1983;82(2):239–44.

Rao DS. Clinical observation of 21 cases of Agkistrodon acutus (Guenther) bite complicated by disseminated intravascular coagulation (author’s transl). Zhonghua Nei Ke Za Zhi. 1981;20(11):670–2.

Hung DZ, Wu TC, Deng JF. The painful experience of inappropriate therapy of snake bites: a report of two cases. Zhonghua Yi Xue Za Zhi (Taipei). 1997;60(6):326–30.

Chen YW, Chen MH, Chen YC, Hung DZ, Chen CK, Yen DHT, et al. Differences in clinical profiles of patients with Protobothrops mucrosquamatus and Viridovipera stejnegeri envenoming in Taiwan. Am J Trop Med Hyg. 2009;80(1):28–32.

Valenta J, Stach Z, Michalek P. Envenoming by Crotalid Snake Chinese Moccasin Agkistrodon Acutus Bite - A Case Report. Prague Med Rep. 2015;116(2):155–60.

Ouyang C, Teng CM. In vivo effects of the purified thrombin-like and anticoagulant principles of Agkistrodon acutus (Hundred pace snake) venom. Toxicon. 1978;16(6):583–93.

Ouyang C, Huang TF. Platelet aggregation inhibitors from Agkistrodon acutus snake venom. Toxicon. 1986;24(11–12):1099–106.

Xu X, Wang C, Liu J, Lu Z. Purification and characterization of hemorrhagic components from Agkistrodon acutus (hundred pace snake) venom. Toxicon. 1981;19(5):633–44.

Xu X, Wang XS, Xi XT, Liu J, Huang JT, Lu ZX. Purification and partial characterization of hyaluronidase from five pace snake (Agkistrodon acutus) venom. Toxicon. 1982;20(6):973–81.

Ouyang C, Teng CM. The effect of the purified anticoagulant principle of Agkistrodon acutus venom on blood coagulation. Toxicon. 1973;11(3):287–92.

Ouyang C, Teng CM, Huang TF. Characterization of the purified principles of Formosan snake venoms which affect blood coagulation and platelet aggregation. J Formos Med Assoc. 1982;81(7):781–90.

Kamiguti AS. Platelets as targets of snake venom metalloproteinases. Toxicon. 2005;45(8):1041–9.

Gold BS, Dart RC, Barish RA. Bites of venomous snakes. N Engl J Med. 2002;347(5):347–56.

Boyer LV, Seifert SA, Cain JS. Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 2. Guidelines for clinical management with crotaline Fab antivenom. Ann Emerg Med. 2001;37(2):196–201.

Chng WJ, Sum C, Kuperan P. Causes of isolated prolonged activated partial thromboplastin time in an acute care general hospital. Singapore Med J. 2005;46(9):450–6.

Isbister GK, Buckley NA, Page CB, Scorgie FE, Lincz LF, Seldon M, et al. A randomized controlled trial of fresh frozen plasma for treating venom-induced consumption coagulopathy in cases of Australian snakebite (ASP-18). J Thromb Haemost. 2013;11(7):1310–8.

Isbister GK. Snakebite doesn’t cause disseminated intravascular coagulation: coagulopathy and thrombotic microangiopathy in snake envenoming. Semin Thromb Hemost. 2010;36(4):444–51.